A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer

Bristol-Myers Squibb (BMS)

Status: Completed

Conditions: Carcinoma, Non-Small-Cell Lung

Study type: Observational

Funder types: Industry

Identifiers

NCT05250817

CA209-69K

Details and patient eligibility

About

The purpose of this observational study is to determine participants' preferences for outcomes associated with first-line treatment of advanced/metastatic Non-Small Cell Lung Cancer (NSCLC) using a discrete-choice experiment (DCE).

Enrollment: 501 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

The following is the inclusion criteria for pretest interviews and final online survey.

Participants:

• Must be 18 years of age or older
• Must be a US resident.
• Lung cancer participants with a physician diagnosis of NSCLC. Global Perspectives will be involved to suggest alternative strategies to a physician-confirmed diagnosis to ensure that actual cancer participants are recruited.

Exclusion criteria

• Not applicable

Other protocol-defined inclusion/exclusion criteria apply

Trial design

501 participants in 2 patient groups

Cohort 1

Description:

Participants with early stage and advanced/metastatic non-small cell lung cancer (NSCLC)

Cohort 2

Description:

Participants from the general population